Further, the expression of Y239F Crk in Crk-null mouse embryonic fibroblasts, glioma and breast cancer led to a marked reduction in the speed of cell migration compared to the reconstitution with wild-type Crk [57]. This evidence concerns the gene CRK and glioma.